Alcon - Governance - Board of Directors
17. Alcon (Novartis AG) | Medical Product Outsourcing
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3T4T5OVXSBPCFG3X5KLSKUSBI4.jpg "ALCC.S - | Stock Price & Latest News | Reuters")
ALCC.S - | Stock Price & Latest News | Reuters
F. Michael Ball — CEO, Alcon at Novartis | Comparably
F. Michael Ball News & Articles | Crain's Chicago Business
Alcon CEO And Leadership: Executives and Demographics - Zippia
Thomas Glanzmann - Director at Alcon | The Org
Untitled
Alcon CEO And Leadership: Executives and Demographics - Zippia
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Michael Francis Land. 12 April 1942—14 December 2020 | Biographical Memoirs of Fellows of the Royal Society
An Investment Review of Alcon Inc. Since Its Spin-off from Novartis
Novartis sees weak Q4 and year, and expects a 2017 repeat, putting Alcon's future in question | Fierce Pharma
Michael F. Land - Wikipedia
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Alcon becomes a separately traded standalone company | Novartis
F. Michael Ball Net Worth (2023) | wallmine
F. Michael Ball News & Articles | Crain's Chicago Business
PR%F the Magazine June 2022 by Food & Beverage Magazine - Issuu
Michael Ball | LinkedIn
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
Thomas Glanzmann - Director at Alcon | The Org
2021 Annual Report Wrapper
